Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Molecular Pharmaceutics|June 16, 2015
Triazine-Substituted and Acyl Hydrazones: Experiment and Computation Reveal a Stability Inversion at Low pHKun Ji, Changsuk Lee, Benjamin G Janesko, et al.
Organic & Biomolecular Chemistry|December 19, 2024
Conservation of structure and dynamic behavior in triazine macrocycles with opportunities for subtle control of hinge motionCasey Patterson-Gardner, Hongjun Pan, Benjamin G Janesko, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Click Chemistry of Melamine Dendrimers: Comparison of "Click-and-Grow" and "Grow-Then-Click" Strategies Using a Divergent Route to DiversitySanami Numai, Risako Yoto, Masataka Kimura, et al.
Chemical Communications (Cambridge, England)|September 16, 2009
Intercepting the synthesis of triazine dendrimers with nucleophilic pharmacophores: a general strategy toward drug delivery vehiclesVincent J Venditto, Kimberly Allred, Clinton D Allred, et al.
RSC Advances|May 2, 2022
Efficient syntheses of macrocycles ranging from 22-28 atoms through spontaneous dimerization to yield bis-hydrazonesVishal R Sharma, Arshad Mehmood, Benjamin G Janesko, et al.
Molecules (Basel, Switzerland)|November 27, 2025
A Competing Hydrogen Bond Network Offers Access to a New Conformation in 24-Atom Triazine MacrocyclesK Harsha Vardan Reddy, Arshad Mehmood, Akop Yepremyan, et al.
International Journal of Pharmaceutics|August 4, 2004
In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug deliveryMichael F Neerman, Wen Zhang, Alan R Parrish, et al.
Molecular Pharmaceutics|December 1, 2011
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseasesMeredith A Mintzer, Eric L Dane, George A O'Toole, et al.
Journal of the American Chemical Society|August 12, 2004
Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug deliveryHui-Ting Chen, Michael F Neerman, Alan R Parrish, et al.
Molecular Pharmaceutics|July 20, 2005
Reduction of drug toxicity using dendrimers based on melamineMichael F Neerman, Hui-Ting Chen, Alan R Parrish, et al.
Pageof 8